Total consolidated operating income for the quarter was 2,633.1 crore, a 22.1 per cent increase from the same quarter last year
Swiggy IPO: Why investors should take a sharp look at Swiggy's path to profitability, potential for operational leverage
Swiggy may eye break-even while augmenting revenue growth and operational leverage, but achieving sustainable profit margins will be key to its valuation story
Indian pharmaceutical major, Dr Reddy's Laboratories share surged 3.1 per cent at Rs 1,312 a piece on the BSE in Wednesday's intraday deals
